Watch Now: One Stock Crorepati Replay is Available Now
Here is the latest financial fact sheet of FAIRCHEM ORGANICS. For more details, see the FAIRCHEM ORGANICS quarterly results and FAIRCHEM ORGANICS share price and chart.
1 Day | % | -2.8 |
No. of shares | m | 13.02 |
1 Week | % | 9.4 |
1 Month | % | 11.3 |
1 Year | % | 0.2 |
52 week H/L | Rs | 2,290.0/1,198.0 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
5-Yr Chart Click to enlarge
|
---|
FAIRCHEM ORGANICS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | 765 | ||||
Low | Rs | NA | 511 | ||||
Sales per share (Unadj.) | Rs | 0 | 304.6 | ||||
Earnings per share (Unadj.) | Rs | 0 | 32.6 | ||||
Diluted earnings per share | Rs | 0 | 32.6 | ||||
Cash flow per share (Unadj.) | Rs | 0 | 37.7 | ||||
Dividends per share (Unadj.) | Rs | 0 | 3.50 | ||||
Adj. dividends per share | Rs | 0.00 | 3.50 | ||||
Avg Dividend yield | % | 0 | 0.5 | ||||
Book value per share (Unadj.) | Rs | 0 | 129.6 | ||||
Adj. book value per share | Rs | 0 | 129.6 | ||||
Shares outstanding (eoy) | m | 0 | 13.02 | ||||
Price / Sales ratio | x | 0 | 2.1 | ||||
Avg P/E ratio | x | 0 | 19.6 | ||||
P/CF ratio (eoy) | x | 0 | 16.9 | ||||
Price / Book Value ratio | x | 0 | 4.9 | ||||
Dividend payout | % | 0 | 10.7 | ||||
Avg Mkt Cap | Rs m | 0 | 8,307 | ||||
Total wages/salary | Rs m | 140 | 161 |
FAIRCHEM ORGANICS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,065 | 3,966 | ||||
Other income | Rs m | 66 | 3 | ||||
Total revenues | Rs m | 3,131 | 3,969 | ||||
Gross profit | Rs m | 484 | 687 | ||||
Depreciation | Rs m | 60 | 66 | ||||
Interest | Rs m | 66 | 68 | ||||
Profit before tax | Rs m | 424 | 556 | ||||
Minority Interest | Rs m | 0 | 0 | ||||
Prior Period Items | Rs m | 0 | 0 | ||||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | ||||
Tax | Rs m | 77 | 131 | ||||
Profit after tax | Rs m | 347 | 425 | ||||
Gross profit margin | % | 15.8 | 17.3 | ||||
Effective tax rate | % | 18.2 | 23.5 | ||||
Net profit margin | % | 11.3 | 10.7 |
FAIRCHEM ORGANICS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 749 | 980 | ||||
Current liabilities | Rs m | 630 | 508 | ||||
Net working cap to sales | % | 3.9 | 11.9 | ||||
Current ratio | x | 1.2 | 1.9 | ||||
Inventory Days | Days | 10 | 4 | ||||
Debtors Days | Days | 451 | 430 | ||||
Net fixed assets | Rs m | 1,440 | 1,606 | ||||
Share capital | Rs m | 0 | 130 | ||||
"Free" reserves | Rs m | 1,137 | 1,557 | ||||
Net worth | Rs m | 1,137 | 1,687 | ||||
Long term debt | Rs m | 163 | 260 | ||||
Total assets | Rs m | 2,189 | 2,586 | ||||
Interest coverage | x | 7.4 | 9.1 | ||||
Debt to equity ratio | x | 0.1 | 0.2 | ||||
Sales to assets ratio | x | 1.4 | 1.5 | ||||
Return on assets | % | 18.9 | 19.1 | ||||
Return on equity | % | 30.5 | 25.2 | ||||
Return on capital | % | 37.7 | 32.0 | ||||
Exports to sales | % | 0 | 0 | ||||
Imports to sales | % | 0 | 0 | ||||
Exports (fob) | Rs m | 0 | 0 | ||||
Imports (cif) | Rs m | 0 | 0 | ||||
Fx inflow | Rs m | 0 | 140 | ||||
Fx outflow | Rs m | 0 | 108 | ||||
Net fx | Rs m | 0 | 32 |
FAIRCHEM ORGANICS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 312 | 394 | ||||
From Investments | Rs m | -239 | -228 | ||||
From Financial Activity | Rs m | -73 | -166 | ||||
Net Cashflow | Rs m | 0 | 0 |
Share Holding
Shareholding as on Mar 2022
|
Company Information
|
CHM: Nahoosh Jayvadan Jariwala | COMP SEC: Rajen Jhaveri | YEAR OF INC: 2019 | BSE CODE: 543252 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
More Chemicals & Pesticides Company Fact Sheets: UPL PIDILITE INDUSTRIES TATA CHEMICALS AARTI INDUSTRIES GFL
Compare FAIRCHEM ORGANICS With: UPL PIDILITE INDUSTRIES TATA CHEMICALS AARTI INDUSTRIES GFL
After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.
Top 5 fertiliser stocks that need to be in your watchlist for 2022.
Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?
The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.
Will the pharma unit's demerger unlock value for shareholders?
What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?
More Views on NewsConstant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.
This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.
Why this may not be the best time to buy smallcaps.
The good side of a market correction? Investors get consistent compounding stocks at a discount.
These value stocks have the potential to deliver good returns in the long run. Watch out for them.
More